Tango Therapeutics TNGX Other Working Capital
Other Working Capital at other companies
Other financials
Where this comes from
Reported directly by Tango Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OtherNoncashIncomeExpense.
The official record: Tango Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tango Therapeutics's other working capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tango Therapeutics's other working capital?
- Tango Therapeutics (TNGX) reported other working capital of -$21K in Q1 2026.
- How has Tango Therapeutics's other working capital changed year-over-year?
- Tango Therapeutics's other working capital decreased by 137.5% year-over-year, from $56K to -$21K.
- What is the long-term trend for Tango Therapeutics's other working capital?
- Over 2 years (2021 to 2025), Tango Therapeutics's other working capital has grown at a -44.9% compound annual growth rate (CAGR), from -$254K to $77K.
- What does other working capital mean?
- Net change in working capital items not separately classified — a residual balancing item.